tetano
Editor, Senior Moderator
J Immunol. 2020 Feb 14. pii: ji1900922. doi: 10.4049/jimmunol.1900922. [Epub ahead of print] [h=1]Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults.[/h]
Avey S[SUP]1[/SUP], Mohanty S[SUP]2[/SUP], Chawla DG[SUP]1[/SUP], Meng H[SUP]3[/SUP], Bandaranayake T[SUP]2[/SUP], Ueda I[SUP]2[/SUP], Zapata HJ[SUP]2[/SUP], Park K[SUP]4[/SUP], Blevins TP[SUP]5[/SUP], Tsang S[SUP]2[/SUP], Belshe RB[SUP]5[/SUP], Kaech SM[SUP]4[/SUP], Shaw AC[SUP]6[/SUP], Kleinstein SH[SUP]7,[/SUP][SUP]3,[/SUP][SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The seasonal influenza vaccine is an important public health tool but is only effective in a subset of individuals. The identification of molecular signatures provides a mechanism to understand the drivers of vaccine-induced immunity. Most previously reported molecular signatures of human influenza vaccination were derived from a single age group or season, ignoring the effects of immunosenescence or vaccine composition. Thus, it remains unclear how immune signatures of vaccine response change with age across multiple seasons. In this study we profile the transcriptional landscape of young and older adults over five consecutive vaccination seasons to identify shared signatures of vaccine response as well as marked seasonal differences. Along with substantial variability in vaccine-induced signatures across seasons, we uncovered a common transcriptional signature 28 days postvaccination in both young and older adults. However, gene expression patterns associated with vaccine-induced Ab responses were distinct in young and older adults; for example, increased expression of killer cell lectin-like receptor B1 (KLRB1; CD161) 28 days postvaccination positively and negatively predicted vaccine-induced Ab responses in young and older adults, respectively. These findings contribute new insights for developing more effective influenza vaccines, particularly in older adults.
Copyright ? 2020 by The American Association of Immunologists, Inc.
PMID: 32060136 DOI: 10.4049/jimmunol.1900922
Avey S[SUP]1[/SUP], Mohanty S[SUP]2[/SUP], Chawla DG[SUP]1[/SUP], Meng H[SUP]3[/SUP], Bandaranayake T[SUP]2[/SUP], Ueda I[SUP]2[/SUP], Zapata HJ[SUP]2[/SUP], Park K[SUP]4[/SUP], Blevins TP[SUP]5[/SUP], Tsang S[SUP]2[/SUP], Belshe RB[SUP]5[/SUP], Kaech SM[SUP]4[/SUP], Shaw AC[SUP]6[/SUP], Kleinstein SH[SUP]7,[/SUP][SUP]3,[/SUP][SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The seasonal influenza vaccine is an important public health tool but is only effective in a subset of individuals. The identification of molecular signatures provides a mechanism to understand the drivers of vaccine-induced immunity. Most previously reported molecular signatures of human influenza vaccination were derived from a single age group or season, ignoring the effects of immunosenescence or vaccine composition. Thus, it remains unclear how immune signatures of vaccine response change with age across multiple seasons. In this study we profile the transcriptional landscape of young and older adults over five consecutive vaccination seasons to identify shared signatures of vaccine response as well as marked seasonal differences. Along with substantial variability in vaccine-induced signatures across seasons, we uncovered a common transcriptional signature 28 days postvaccination in both young and older adults. However, gene expression patterns associated with vaccine-induced Ab responses were distinct in young and older adults; for example, increased expression of killer cell lectin-like receptor B1 (KLRB1; CD161) 28 days postvaccination positively and negatively predicted vaccine-induced Ab responses in young and older adults, respectively. These findings contribute new insights for developing more effective influenza vaccines, particularly in older adults.
Copyright ? 2020 by The American Association of Immunologists, Inc.
PMID: 32060136 DOI: 10.4049/jimmunol.1900922